About the Authors
- Geraldine Perkins
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Timothy A. Yap
-
Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Lorna Pope
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Amy M. Cassidy
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Juliet P. Dukes
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Ruth Riisnaes
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Christophe Massard
-
Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Philippe A. Cassier
-
Affiliation Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Susana Miranda
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Jeremy Clark
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Katie A. Denholm
-
Affiliation Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Khin Thway
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- David Gonzalez De Castro
-
Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
- Gerhardt Attard
-
Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- L. Rhoda Molife
-
Affiliation Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Stan B. Kaye
-
Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Udai Banerji
-
Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
- Johann S. de Bono
-
* E-mail: johann.de-bono@icr.ac.uk
Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: GP TAY JSDB. Performed the experiments: GP TAY LP JPD RR CM PAC SM JC KAD KT DGDC LRM SBK UB. Analyzed the data: GP TAY LP AMC JPD RR GA JSDB. Wrote the paper: GP TAY JSDB.